Citation:david r.Koolbergen,md article title.Follow-up after tricuspid valve surgery in adult patients with systemic right ventricles journal title: european journal of cardio-thoracic surgery 2016, 50: 456¿463 10.1093/ejcts/ezw059 earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature regarding the evaluation of mid-term functional improvements, echocardiographic findings and survival after tricuspid valve (tv) surgery in patients with congenitally corrected transposition of the great arteries (cctga) or after atrial (mustard or senning) correction for transposition of the great arteries (actga), the right ventricle (rv) supports the systemic circulation.All data were collected from multiple centers between july 1999 to november 2014.The study population included 26 patients (predominantly female, mean age 37 years, 1 of which was implanted with medtronic mosaic (serial numbers not provided).Among all patients adverse events included: arrhythmias, renal insufficiency, re-operation, bleeding, tricuspid stenosis, tricuspid regurgitation, sepsis, pneumonia and congestive heart failure (chf).Multiple manufacturers were noted in the literature; based on the available information a direct correlation could not be made between the observed adverse events and a medtronic product.No additional adverse patient effects or product performance issues were reported.
|